You are here

Eli Lilly

One COVID-19 opportunity for pharma? A chance to bolster its reputation, Lilly CEO says

Fierce Pharma

Thu, 04/23/20 - 09:27 pm

pharma industry

Eli Lilly Reports First-Quarter Results, Adjusts Guidance

Motley Fool

Thu, 04/23/20 - 09:19 pm

Can a popular class of diabetes drugs that includes Merck's Januvia help treat COVID-19?

Fierce Biotech

Wed, 04/15/20 - 10:52 am

Boehringer Ingelheim

AZ, Lilly join efforts to develop drugs for COVID-19

Pharmaforum

Tue, 04/14/20 - 09:50 am

Eli Lilly Starts Clinical Trial for Potential COVID-19 Treatment

Motley Fool

Mon, 04/13/20 - 10:54 am

clinical trials

Biopharma acquisitions slow, but it's not Covid-19's fault yet

EP Vantage

Wed, 04/8/20 - 10:28 am

Gilead Sciences

ANI Pharmaceuticals

Amerigen Pharma

Eli Lilly lowers insulin costs as coronavirus crisis deepens

Yahoo/Reuters

Tue, 04/7/20 - 10:55 am

Pfizer, Merck, and Eli Lilly Will Pay Their Doctors to Get Back to Treating Patients During the COVID-19 Pandemic

Motley Fool

Thu, 04/2/20 - 11:54 pm

Lilly ad campaign in U.S. newspapers offers diabetes med help for patients affected by COVID-19 shutdowns

Fierce Pharma

Tue, 03/31/20 - 10:53 pm

Lilly pays Sitryx $50M upfront for preclinical autoimmune assets

Fierce Biotech

Tue, 03/31/20 - 11:06 am

autoimmune disease

Pharma giants including Novartis collaborate on COVID-19 therapies

Pharmaforum

Thu, 03/26/20 - 10:38 am

Boehringer Ingelheim

Gilead Sciences

COVID-19 prompts Pfizer to stop enrollment in most studies

Fierce Pharma

Thu, 03/26/20 - 10:33 am

Bristol-Myers Squibb

clinical trials

Lilly, Galapagos halt trials as coronavirus deepens impact on drug research

BioPharma Dive

Mon, 03/23/20 - 12:00 pm

clinical trials

FDA blocks Lilly, Boehringer's Jardiance from coveted Type 1 diabetes nod

Fierce Pharma

Mon, 03/23/20 - 11:54 am

Boehringer Ingelheim

type 1 diabetes

Eli Lilly Will Provide Drive-Through Coronavirus Testing to Indianapolis Healthcare Workers

Motley Fool

Sun, 03/22/20 - 11:50 pm

Lilly CEO Ricks scores big pay bump to $21.3M, beating out other Big Pharma CEOs

Fierce Pharma

Wed, 03/18/20 - 11:40 pm

Lilly, Incyte get FDA breakthrough therapy status for baricitinib to treat alopecia areata

Pharmaceutical Business Review

Tue, 03/17/20 - 11:59 am

breakthrough therapy

alopecia areata

Eli Lilly teams with NIH, antibody upstart AbCellera in coronavirus hunt

Endpoints

Fri, 03/13/20 - 10:57 am

Lilly and Boehringer's Jardiance, chasing AZ, nabs speedy FDA review in kidney disease

Fierce Pharma

Thu, 03/12/20 - 10:57 pm

Boehringer Ingelheim

How Biogen and Other Biopharma Companies Are Responding to COVID-19

BioSpace

Tue, 03/10/20 - 01:01 pm

pharma industry

Pages